Abstract
British Journal of Clinical PharmacologyVolume 11, Issue 1 p. 101-102 Free Access Salivary elimination of pyrimethamine. RA Ahmad, RA AhmadSearch for more papers by this authorHJ Rogers, HJ RogersSearch for more papers by this author RA Ahmad, RA AhmadSearch for more papers by this authorHJ Rogers, HJ RogersSearch for more papers by this author First published: January 1981 https://doi.org/10.1111/j.1365-2125.1981.tb01114.xCitations: 7AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References AHMAD, R.A. & ROGERS, H.J. (1980). Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine. Br. J. clin. Pharmac. 10, 519– 524. CAVALLITO, C.A., NICHOL, C.A., BRENCKMAN, W.D., DE ANGELIS, R.L., STICKNEY, D.R., SIMMONS, W.S. & SIGEL, C.W. (1978). Lipid-soluble inhibitors of dihydrofolate reductase I. Kinetics, tissue distribution and extent of metabolism of pyrimethamine, metoprine and etoprine in the rat, dog and man. Drug Metab. Dispos. 6, 329– 337. COHN, V.H. (1971). Transmembrane movement of drug molecules. In Fundamentals of drug metabolism and drug disposition, eds., B.N. Du, H.G. Mandel & E.L. Way p. 18.Baltimore: Williams & Wilkins. DANHOF, M. & BREIMER, D.D. (1978). Therapeutic drug monitoring in saliva. Clin. Pharmacokin, 3, 39– 57. GALEAZZI, R.L., BENET, L. & SHEINER, L.B. (1976). Relationship between the pharmacokinetics and pharmacodynamics of procainamide. Clin. Pharmac. Ther., 20, 278– 289. GEILS, G.F., SCOTT, C.W., BAUGH, C.M. & BUTTERWORTH, C.E. (1971). Treatment of meningeal leukaemia with pyrimethamine. Blood, 38, 131– 137. JONES, C.R. & OVENALL, S.M. (1979). Determination of plasma concentrations of dapsone, monoacetyl dapsone and pyrimethamine in human subjects doses with malo-prim. J. Chromatogr., 163, 179– 185. MATIN, S.B., WAN, S.H. & KARAM, J.H. (1974). Pharmacokinetics of tolbutamide: prediction by concentration in saliva. Clin. Pharmac. Ther., 16, 1052– 1058. SMITH, C.C. & IHRIG, J. (1959). Persistent excretion of pyrimethamine following oral administration. Am. J. Trop. Med. Hyg., 8, 60– 62. Citing Literature Volume11, Issue1January 1981Pages 101-102 ReferencesRelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
